This content is Free Access.
1Department of Cell Biology and Anatomy, College of Medicine,University of Arizona, Tucson, 2Southern Arizona Veterans Affairs Health Care System,Tucson, AZ, 3Department of Surgery, College of Medicine,University of Arizona, Tucson, 4Biomedical Diagnostics and Research,Tucson, AZ, 5Department of Medicine, College of Medicine,University of Arizona, Tucson
Chapters
- 00:05Title
- 01:47Introduction
- 03:04Preparing Tissues
- 04:15Immunostaining
- 08:16Evaluating Tissue Sections
- 27:11Conclusion
Reduced/absent expression of Pms2 and/or ERCC1 in entire crypts is a frequent event within 10 cm on each side of colonic adenocarcinomas, likely the basis of a field defect with high mutability and progression to cancer. Deficiency in Ku86 or CcOI is much less frequent in these field defects.
Tags
Deficient Pms2Deficient ERCC1Deficient Ku86Deficient CcOIField DefectColon CancerCarcinogenesisMolecular AbnormalitiesColonic AdenocarcinomaAdenoma With Advanced NeoplasiaImmunohistochemistryDNA Repair ProteinsApoptosisDNA Mismatch RepairDNA Nucleotide Excision RepairApoptosis ResistanceMutabilityProgression To Colon CancerDNA Non-homologous End JoiningCytochrome C Oxidase Subunit
